Last Updated on January 5, 2024 by The Health Master
New Delhi: NPPA fixes retail price of 7 drug formulations, through a recent notification.
The apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) fixes retail price of 7 drug formulations in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013.
For notification, Click here
The retail price of 7 drug formulations fixation are exclusive of goods and services tax (GST).
NPPA fixes retail price of 7 drug formulations include combination drug are as under:
Clarithromycin + Esomeprazole + Amoxicillin Tablet;
Bictegravir + Emtricitabine + Tenofovir Tablet,
Ranitidine Hydrochloride + Dicyclomine Hydrochloride + Simethicone Tablet;
Darunavir + Ritonavir Tablet;
Cefotaxime Sodium Injection;
Clobazam Tablet 7.5 mg
Clobazam Tablet 2.5 mg
Various drugmakers including the following are involved in manufacturing the said drug formulations under different brand names:
Sun Pharmaceuticals Ltd.,
Alkem Lab, Aurobindo Pharma,
Emcure Pharma,
Hetero Lab,
Mankind Pharma,
Windlas Biotech
Malik Lifesciences
The formulations mentioned in the list include antibiotics, indicated to treat a variety of bacterial infections; an antiviral medicine that prevents human immunodeficiency virus (HIV) from multiplying; seizures drug and others.
Also read another news of NPPA, Click the links below
NPPA fixes price of 2 inhaler devices
NPPA fixes retail prices of 75 formulations under DPCO 2013
NPPA fixes retail prices of 12 formulations
NPPA fixes retail prices of 21 formulations
